CCL2 and nonpapillary renal cell carcinoma: The research effectively pinpointed critical prognostic markers and crafted a forecasting model that achieved a C‐index of 0.650, highlighting the significant impact of immune cell infiltration, especially CCL2+ neoplastic cells, on ccRCC patient prognosis.